Mayur Ramesh

9PUBLICATIONS
48CO-AUTHORS
Major global burdens of diseaseImmunogenetics (incl. genetic immunology)Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 25, 2025
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults With Respiratory Syncytial Virus.

Kevin C Ma, Diya Surie, Yuwei Zhu

|Apr 08, 2025
Vaccine Effectiveness Against Influenza A(H1N1), A(H3N2), and B-Associated Hospitalizations, United States, 1 September 2023 to 31 May 2024.

Nathaniel M Lewis, Elizabeth J Harker, Seana Cleary

|Nov 28, 2024
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study.

Nathaniel M Lewis, Elizabeth J Harker, Lauren B Grant

|May 03, 2024
Impact of time to treatment in first occurrence, non-severe Clostridioides difficile infection for elderly patients: are we waiting too long to treat?

Rhett Vandervelde, Mark E Mlynarek, Mayur Ramesh

|Dec 05, 2023
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.

Nathaniel M Lewis, Yuwei Zhu, Ithan D Peltan

|Jul 21, 2022
Real-world Experience of Sotrovimab in High-risk, Immunocompromised COVID-19 Patients.

Navina K Birk, Saniya Jain, Louis Massoud

Pageof 2